Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolf Marschalek

Showing results (31-40 of 187) with videos related to

Pageof 19
Sort By:
American Journal of Blood Research|March 21, 2012
Premature transcript termination, trans-splicing and DNA repair: a vicious path to cancerEric Kowarz, Jennifer Merkens, Michael Karas, et al.
Frontiers in Pharmacology|January 29, 2025
MLL-AF4 upregulates 5-lipoxygenase expression in t(4;11) leukemia cells via the ALOX5 core promoterMarius Hyprath, Maximilian Molitor, Ilona Schweighöfer, et al.
Annals of Laboratory Medicine|July 11, 2012
Diagnostic usefulness of genomic breakpoint analysis of various gene rearrangements in acute leukemias: a perspective of long distance- or long distance inverse-PCR-based approachesJohn Jeongseok Yang, Rolf Marschalek, Claus Meyer, et al.
Nucleic Acids Research|April 30, 2010
Transcriptional properties of human NANOG1 and NANOG2 in acute leukemic cellsIrina Eberle, Birgit Pless, Miriam Braun, et al.
Iscience|June 28, 2023
How chromosomal translocations arise to cause cancer: Gene proximity, <i>trans</i>-splicing, and DNA end joiningPatrick Streb, Eric Kowarz, Tamara Benz, et al.
Carcinogenesis|January 27, 2004
Recombination at chromosomal sequences involved in leukaemogenic rearrangements is differentially regulated by p53Gisa S Boehden, Anja Restle, Rolf Marschalek, et al.
British Journal of Haematology|March 12, 2002
A highly specific and sensitive fluorescence in situ hybridization assay for the detection of t(4;11)(q21;q23) and concurrent submicroscopic deletions in acute leukaemiasMargit König, Martin Reichel, Rolf Marschalek, et al.
Ebiomedicine|July 3, 2015
Unraveling the Activation Mechanism of Taspase1 which Controls the Oncogenic AF4-MLL Fusion ProteinSamaneh Sabiani, Tim Geppert, Christian Engelbrecht, et al.
ALTEX|April 21, 2026
Serum-free in vitro assessment of receptor-mediated endocrine activity including Phase-1 metabolismInska Reichstein, Denise Horte, Rolf Marschalek, et al.
Oncotarget|November 16, 2017
The AF4-MLL fusion transiently augments multilineage hematopoietic engraftment but is not sufficient to initiate leukemia in cord blood CD34<sup>+</sup> cellsCristina Prieto, Rolf Marschalek, Alessa Kühn, et al.
Pageof 19

Showing results (31-40 of 187) with videos related to

Sort By:
Pageof 19
American Journal of Blood Research|March 21, 2012
Premature transcript termination, trans-splicing and DNA repair: a vicious path to cancerEric Kowarz, Jennifer Merkens, Michael Karas, et al.
Frontiers in Pharmacology|January 29, 2025
MLL-AF4 upregulates 5-lipoxygenase expression in t(4;11) leukemia cells via the ALOX5 core promoterMarius Hyprath, Maximilian Molitor, Ilona Schweighöfer, et al.
Annals of Laboratory Medicine|July 11, 2012
Diagnostic usefulness of genomic breakpoint analysis of various gene rearrangements in acute leukemias: a perspective of long distance- or long distance inverse-PCR-based approachesJohn Jeongseok Yang, Rolf Marschalek, Claus Meyer, et al.
Nucleic Acids Research|April 30, 2010
Transcriptional properties of human NANOG1 and NANOG2 in acute leukemic cellsIrina Eberle, Birgit Pless, Miriam Braun, et al.
Iscience|June 28, 2023
How chromosomal translocations arise to cause cancer: Gene proximity, <i>trans</i>-splicing, and DNA end joiningPatrick Streb, Eric Kowarz, Tamara Benz, et al.
Carcinogenesis|January 27, 2004
Recombination at chromosomal sequences involved in leukaemogenic rearrangements is differentially regulated by p53Gisa S Boehden, Anja Restle, Rolf Marschalek, et al.
British Journal of Haematology|March 12, 2002
A highly specific and sensitive fluorescence in situ hybridization assay for the detection of t(4;11)(q21;q23) and concurrent submicroscopic deletions in acute leukaemiasMargit König, Martin Reichel, Rolf Marschalek, et al.
Ebiomedicine|July 3, 2015
Unraveling the Activation Mechanism of Taspase1 which Controls the Oncogenic AF4-MLL Fusion ProteinSamaneh Sabiani, Tim Geppert, Christian Engelbrecht, et al.
ALTEX|April 21, 2026
Serum-free in vitro assessment of receptor-mediated endocrine activity including Phase-1 metabolismInska Reichstein, Denise Horte, Rolf Marschalek, et al.
Oncotarget|November 16, 2017
The AF4-MLL fusion transiently augments multilineage hematopoietic engraftment but is not sufficient to initiate leukemia in cord blood CD34<sup>+</sup> cellsCristina Prieto, Rolf Marschalek, Alessa Kühn, et al.
Pageof 19